Combination therapy with SGLT2-inhibitors and Tafamidis in transthyretin cardiomyopathy [0.03%]
SGLT2抑制剂与塔法莫迪斯在 ATTR心肌病中联合治疗的效果
Kevin Chung,Ramzi Ibrahim,Mahmoud Abdelnabi et al.
Kevin Chung et al.
Background: Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive disease associated with high morbidity and mortality. Tafamidis is the only US Food and Drug Administration-approved disease-modifying therapy. S...
Nationwide one-year outcomes in acute myocardial infarction-related cardiogenic shock with a focus on broad-anterior myocardial infarction: Insights from a Japanese registry [0.03%]
日本注册的急性心肌梗死相关性心源性休克全国1年预后：前壁心肌梗死患者的特征及预后分析
Riku Arai,Kyohei Yamaji,Shun Kohsaka et al.
Riku Arai et al.
Background: The one-year prognosis for patients with acute myocardial infarction complicated by cardiogenic shock (AMI-CS) undergoing percutaneous coronary intervention (PCI) has not been sufficiently characterized, parti...
Association between insomnia symptoms and risk of heart failure: A meta-analysis of prospective cohort studies [0.03%]
失眠与心力衰竭发病风险的关系——一项前瞻性队列研究的 Meta 分析
Juan Gao,Hong-Shuai Cao,Le Han et al.
Juan Gao et al.
Background: Insomnia, as one of the most prevalent sleep disorders, is frequently linked to heart failure (HF). However, the precise relationship and potential risk of HF events associated with insomnia and subtypes of sy...
Contemporary clinical implication of catheter ablation for atrial fibrillation in Japan [0.03%]
日本心房颤动导管消融的现代临床意义分析
Naoya Kataoka,Teruhiko Imamura
Naoya Kataoka
Right ventricular outflow tract reconstruction in cyanotic congenital heart disease: A single center comparison between homograft and handmade polytetrafluoroethylene tri-leaflet valved conduit [0.03%]
法四术后右室流出道病变的修复治疗——同种异体肺动脉瓣和自制PTFE三叶瓣的价值比较研究
Qi Liu,Shoujun Li,Keming Yang et al.
Qi Liu et al.
Background: The comparative clinical outcomes of homograft (HG) and handmade polytetrafluoroethylene (PTFE) tri-leaflet valved conduit for right ventricular outflow tract reconstruction (RVOTR) in children with cyanotic c...
Antiarrhythmic Potential of SGLT2 Inhibitors: Mechanistic Insights and Clinical Evidence [0.03%]
钠-葡萄糖协同转运蛋白2抑制剂的抗心律失常潜力：机制见解和临床证据
Shinya Fujiki
Shinya Fujiki
Sodium-glucose cotransporter 2 (SGLT2) inhibitors were originally developed to treat type 2 diabetes by promoting glycosuria through inhibition of renal glucose reabsorption. However, their clinical utility has expanded rapidly following th...
The prognostic value of pre-implantation hyponatremia in pacemaker recipients: A population-based study [0.03%]
起搏器植入者的术前低钠血症预后价值：基于人口的队列研究
Yuval Avidan,Dana Hadar,Hila Cohen et al.
Yuval Avidan et al.
Beyond acute survival: Addressing long-term implications of size mismatch in obese heart transplant patients [0.03%]
超越急性生存：解决肥胖心脏移植患者大小错配的长期影响
Parth Aphale,Himanshu Shekhar,Shashank Dokania
Parth Aphale
Patient perceptions on cardiac rehabilitation participation following hospitalization for acute coronary syndrome [0.03%]
急性冠脉综合征住院患者的心脏康复参与情况及其影响因素
Momoko Masuda,Kazuki Tobita,Ayumi Goda et al.
Momoko Masuda et al.